glutamic acid has been researched along with aspirin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 16 (66.67) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Grilli, M; Memo, M; Pizzi, M; Spano, P | 1 |
| Kosten, TR | 1 |
| Casper, D; Rempel, N; Werner, P; Yaparpalvi, U | 1 |
| Cechinel-Filho, V; Corrêa, R; Golin, V; Neto, RA; Nunes, RJ; Souza, MM; Stiz, DS; Yunes, RA | 1 |
| Balakin, AA; Dodonov, AF; Novikova, LI; Talrose, VL | 1 |
| Camarero, J; Castillo, J; Colado, MI; Dávalos, A; De Cristóbal, J; Leza, JC; Lizasoain, I; Lorenzo, P; Moro, MA | 1 |
| Choi, SS; Lee, JK; Suh, HW | 1 |
| Cárdenas, A; De Cristóbal, J; Fernández-Tomé, P; Leza, JC; Lizasoain, I; Lorenzo, P; Moro, MA | 1 |
| De Cristóbal, J; Leza, JC; Lizasoain, I; Lorenzo, P; Madrigal, JL; Moro, MA | 1 |
| Lorenzo Fernández, P | 1 |
| Castillo, J; Dávalos, A; Leira, R; Lizasoain, I; Moro, MA; Serena, J | 1 |
| Arakawa, M; Ishige, K; Ito, Y; Saito, H; Tanaka, M | 1 |
| Wang, SJ | 1 |
| Chang, CP; Huang, WT; Kao, TY; Lin, MT | 1 |
| Berger, C; Schwab, S; Sommer, C; Stauder, A; Xia, F | 1 |
| Chen, Y; Cui, G; Lee, KH; Morris-Natschke, S; Peng, S; Qian, K; Wang, C; Zhao, M | 1 |
| Coll, C; Fernández, MA; Filinger, EJ; Lemberg, A; Perazzo, JC; Romay, S; Rosello, DO | 1 |
| Cechinel-Filho, V; Corrêa, R; de Campos-Buzzi, F; Delle Monache, F; Fracasso, M; Niero, R; Padaratz, P | 1 |
| Del Soldata, P; Ji, D; Majid, AS; Osborne, NN; Sparatore, A | 1 |
| Hamzah, AS; Kek, TL; Mansor, NS; Mohammat, MF; Salleh, MZ; Sani, MH; Shaameri, Z; Zakaria, ZA | 1 |
| Bezzi, P; Cali, C; Lopatar, J; Petrelli, F; Pucci, L | 1 |
| Du, J; Li, WQ; Li, XH; Li, YJ; Peng, J; Wu, YH; Yang, YM; Zhang, W | 1 |
| He, B; Liu, F; Tan, S; Xu, M; Zhou, W | 1 |
1 review(s) available for glutamic acid and aspirin
| Article | Year |
|---|---|
Pharmacotherapy of cerebral ischemia in cocaine dependence.
Topics: Aspirin; Brain; Brain Ischemia; Cerebrovascular Circulation; Cocaine; Cocaine-Related Disorders; Cognition Disorders; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Intracranial Embolism and Thrombosis; Male; Nerve Degeneration; Neuropsychological Tests; Platelet Aggregation Inhibitors; Radionuclide Imaging; Substance Withdrawal Syndrome | 1998 |
23 other study(ies) available for glutamic acid and aspirin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.
Topics: Animals; Aspirin; Calcium; Cell Survival; Cells, Cultured; Cerebellum; Dentate Gyrus; Glutamic Acid; Hippocampus; In Vitro Techniques; N-Methylaspartate; Neurons; Neuroprotective Agents; NF-kappa B; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Sodium Salicylate; Transcription Factor AP-1; Up-Regulation | 1996 |
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
Topics: Acetaminophen; Animals; Aspirin; Cell Count; Cells, Cultured; Dopamine; Fetus; Glutamic Acid; Ibuprofen; Mesencephalon; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Rats | 2000 |
Antinociceptive properties of N-aryl-glutaramic acids and N-aryl-glutarimides.
Topics: Acetic Acid; Analgesics; Aspirin; Chromatography, Thin Layer; Formaldehyde; Glutamic Acid; Humans; Indomethacin; Magnetic Resonance Spectroscopy; Muscle Contraction; Pain; Pain Measurement; Piperidones; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 2000 |
The solvent shells of cluster ions produced by direct electric field extraction from glycerol/water mixtures.
Topics: Algorithms; Amino Acids; Ascorbic Acid; Aspartic Acid; Aspirin; Glutamic Acid; Glycerol; Hydrocarbons, Halogenated; Ions; Membranes; Models, Theoretical; Molecular Structure; Niacin; Salicylic Acid; Spectrometry, Mass, Electrospray Ionization; Water | 2001 |
Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats.
Topics: Adenosine Triphosphate; Animals; Aspirin; Brain; Brain Ischemia; Cerebral Infarction; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Male; Neuroprotective Agents; Osmolar Concentration; Rats; Rats, Inbred F344 | 2001 |
Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Aspirin; Behavior, Animal; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Foot; Glutamic Acid; Male; Mice; Mice, Inbred ICR; Nociceptors; Pain; Pain Measurement; Receptors, Glutamate; Receptors, Neurokinin-1; Spinal Cord; Substance P; Synaptic Transmission | 2001 |
Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation.
Topics: Adenosine Triphosphate; Animals; Aspirin; Biological Transport; Brain; Brain Ischemia; Cell Death; Cell Hypoxia; Cell Respiration; Cells, Cultured; Glucose; Glutamic Acid; Mitochondria; Neurons; Neuroprotective Agents; Oxygen Consumption; Rats; Rats, Wistar | 2002 |
Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Cerebral Cortex; Glutamic Acid; Immobilization; Male; Nerve Degeneration; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidation-Reduction; Rats; Rats, Wistar; Reference Values; Stress, Physiological; Tumor Necrosis Factor-alpha | 2002 |
[Neuroprotection by aspirin in cerebrovascular pathology].
Topics: Adenosine Triphosphate; Algorithms; Amino Acid Transport System X-AG; Animals; Aspirin; Brain Ischemia; Cell Death; Cerebrovascular Disorders; Clinical Trials as Topic; Disease Models, Animal; Glucose; Glutamic Acid; Humans; Indomethacin; Mitochondria; Neuroprotective Agents; Oxygen; Salicylates | 2002 |
Neuroprotective effects of aspirin in patients with acute cerebral infarction.
Topics: Acute Disease; Aged; Aspirin; Brain Infarction; Confidence Intervals; Glutamic Acid; Humans; Middle Aged; Neuroprotective Agents; Odds Ratio | 2003 |
Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Topics: Amino Acid Transport System y+; Animals; Aspirin; Cell Death; Cell Line, Transformed; Cell Survival; Cyclooxygenase Inhibitors; Cystine; Glutamic Acid; I-kappa B Proteins; Mice; Nerve Degeneration; Neurons; NF-kappa B; NF-kappa B p50 Subunit; Oligonucleotides, Antisense; Oxidative Stress; Proto-Oncogene Proteins c-rel; Transcription Factor RelA | 2005 |
Facilitatory effect of aspirin on glutamate release from rat hippocampal nerve terminals: involvement of protein kinase C pathway.
Topics: Animals; Aspirin; Calcium Channel Blockers; Glutamic Acid; Hippocampus; Male; Nerve Endings; Protein Kinase C; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence | 2006 |
Aspirin may exert its antipyresis by inhibiting the N-methyl-D-aspartate receptor-dependent hydroxyl radical pathways in the hypothalamus.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dinoprostone; Fever; Glutamic Acid; Hydroxyl Radical; Hypothalamus; Lipopolysaccharides; Male; Microdialysis; Rabbits; Receptors, N-Methyl-D-Aspartate; Stereotaxic Techniques | 2007 |
Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia.
Topics: Analysis of Variance; Animals; Aspirin; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glutamic Acid; Interleukin-6; Ischemic Attack, Transient; Male; Neuroprotective Agents; Peroxidase; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Time Factors | 2008 |
Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing L-Arg and L-Asp or L-Glu.
Topics: Animals; Arginine; Aspartic Acid; Aspirin; Circular Dichroism; Dose-Response Relationship, Drug; Fibrinolytic Agents; Glutamic Acid; Nanostructures; Oligopeptides; Particle Size; Platelet Aggregation Inhibitors; Rats; Thrombosis | 2008 |
Reyes's syndrome, encephalopathy, hyperammonemia and acetyl salicylic acid ingestion in a city hospital of Buenos Aires, Argentina.
Topics: Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Argentina; Aspartate Aminotransferases; Aspirin; Astrocytes; Child; Child, Preschool; Female; Glutamic Acid; Humans; Hyperammonemia; Hyperbilirubinemia; Male; Mitochondrial Swelling; Retrospective Studies; Reye Syndrome | 2009 |
Antinociceptive activity of a new benzofuranone derived from a chalcone.
Topics: Acetaminophen; Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Benzofurans; Capsaicin; Chalcone; Dose-Response Relationship, Drug; Formaldehyde; Glutamic Acid; Linear Models; Male; Mice; Nociception; Pain; Pain Measurement | 2009 |
Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14).
Topics: Aspirin; Base Sequence; Cell Line, Transformed; DNA Primers; Glutamic Acid; Glutathione; Hydrogen Sulfide; Imidazoles; Immunohistochemistry; Indoles; Oxidative Stress; Polymerase Chain Reaction; Reactive Oxygen Species | 2012 |
Antinociceptive activity of a synthetic oxopyrrolidine-based compound, ASH21374, and determination of its possible mechanisms.
Topics: Analgesics; Analgesics, Opioid; Animals; Aspirin; Capsaicin; Cyclic GMP; Glutamic Acid; Male; Mice; Mice, Inbred BALB C; Morphine; Motor Activity; Naloxone; Naltrexone; Nitric Oxide; Pyrrolidines; Rats, Sprague-Dawley; Receptors, Opioid | 2013 |
G-protein coupled receptor-evoked glutamate exocytosis from astrocytes: role of prostaglandins.
Topics: Animals; Antibodies, Blocking; Aspirin; Astrocytes; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Exocytosis; Glutamic Acid; Image Processing, Computer-Assisted; Immunohistochemistry; Indomethacin; Methoxyhydroxyphenylglycol; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Transfection; Vesicular Glutamate Transport Protein 1 | 2014 |
Involvement of glutamate-cystine/glutamate transporter system in aspirin-induced acute gastric mucosa injury.
Topics: Amino Acid Transport System X-AG; Amino Acid Transport System y+; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Gastric Mucosa; Glutamic Acid; Humans; Male; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 2014 |
Preparation and preliminary quality evaluation of aspirin/L-glutamate compound pellets.
Topics: Animals; Aspirin; Chemistry, Pharmaceutical; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Compounding; Drug Evaluation, Preclinical; Gastric Mucosa; Gastrointestinal Tract; Glutamic Acid; Quality Control; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Tablets, Enteric-Coated | 2021 |